Therefore, it is anticipated that a combination of DPP-4 inhibitor and SU may synergistically stimulate insulin secretion and effectively ameliorate hyperglycemia in type 2 diabetes mellitus. This evidence concerns the gene INS and type 2 diabetes mellitus.